Telos Biotech parent, Cambrian Bio, to develop robust cell therapies for treating age-related diseases
Longevity Technology - 27-Jun-2023Novel recombinant protein to manufacture biologically fit cells by safely lengthening telomeres
Cambrian Biopharma
A distributed drug discovery company
Cambrian is a distributed drug discovery company, or a “DisCo.” It partners with leading academic institutions and start-up companies, providing capital and expertise to advance a portfolio of drug development programs targeting nine hallmarks of ageing.
Visit website: https://www.cambrianbio.com/
Details last updated 10-Feb-2021
Cambrian Biopharma News
Reason reports back from Age-Related Disease Therapeutics Summit 2023
Fight Aging! - 16-Jun-2023Many people believe lots of clinical trials of novel therapeutics targeting mechanisms of aging will start up in the next few years
Cambrian Bio launches new company for aging-related disease treatments
Longevity Technology - 14-Mar-2023Early trials show the drug is safe, and a new study will begin soon
Korify Capital plans to invest $100m in longevity and mental health space
FierceBiotech - 22-Dec-2021Aiming to invest in 15-20 biotech firms, including Cambrian Biopharma, to target drivers of ageing
A proactive step for next generation drug discovery by Cambrian Biopharma
Longevity Technology - 26-Oct-2021Novel business approach helps people to live longer with good health
Display all news
People at Cambrian Biopharma
James Peyer
Stem cell biologist out to build biotech companies focused on age-related diseases, CEO at Cambrian Biopharma
